Insider Stock Trading History of Bay City Capital Fund V Co-investment Fund, L.p.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Bay City Capital Fund V Co-investment Fund, L.p. since year 2005. The trader's CIK number is 1409813. At the time of this reporting, Bay City Capital Fund V Co-investment Fund, L.p. is the 10% Owner of Sunesis Pharmaceuticals Inc . (stock ticker symbol SNSS). See this page for all insider trading activities at Sunesis Pharmaceuticals Inc .

Note that in the past Bay City Capital Fund V Co-Investment Fund, L.P. also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Bay City Capital Fund V Co-investment Fund, L.p. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-07-24 SNSS Sunesis Pharmaceuticals Inc Sale 635,702 3.46 2,199,528
2014-10-08 DERM Dermira, Inc. Buy 69,112 16.00 1,105,792
2014-08-28 SNSS Sunesis Pharmaceuticals Inc Sale 200,000 7.88 1,577,000
2014-08-27 SNSS Sunesis Pharmaceuticals Inc Sale 100,700 8.16 822,014
2014-08-08 SNSS Sunesis Pharmaceuticals Inc Sale 675,000 6.62 4,468,500
2014-08-11 SNSS Sunesis Pharmaceuticals Inc Sale 31,600 6.90 218,103
2014-08-12 SNSS Sunesis Pharmaceuticals Inc Sale 37,100 6.77 251,241
2013-05-28 HPTX Hyperion Therapeutics Inc Sale 12,000 21.08 252,959
2013-05-30 HPTX Hyperion Therapeutics Inc Sale 5,366 21.00 112,686
2013-05-17 HPTX Hyperion Therapeutics Inc Sale 129,455 22.69 2,937,333
2013-05-20 HPTX Hyperion Therapeutics Inc Sale 2,000 22.24 44,480
2010-06-30 SNSS Sunesis Pharmaceuticals Inc Buy 23,824,450 .28 6,551,723

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bay City Capital Fund V Co-investment Fund, L.p. (10% Owner of Sunesis Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.